Published in Cancer Weekly, November 27th, 2001
Cell Genesys ended the quarter with approximately $220 million in cash, cash equivalents, and short-term investments. Revenues for the quarter were $4.6 million, compared with $5.1 million...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.